Developer docs
API playgroundTry for free, no card

Search company profiles

snapIoT

Full company profile

uuid000fg24

Namestring
snapIoT
Legal namestring
Fortrea Inc.
Websiteurl
snapiot.com
Company typeenum
Public
Founded yearint
2016
Descriptiontext

snapIoT is a privately held, San Diego-based clinical technology company founded in 2016. Per its own short description, snapIoT is "a clinical platform that designs to create, launch, and manage clinical trials." The company operates with 11-50 employees and is led by co-founder, CEO, and board member Isaac Eteminan. No additional product-level detail, technology stack, pricing model, or revenue mechanics are disclosed in the available data.

The business model is not explicitly stated beyond the platform's described function. By inference from the company description, snapIoT likely sells tooling or services to organizations conducting clinical trials (e.g., sponsors, CROs, sites), but the absence of pricing disclosures, named customers, and go-to-market detail means the revenue mechanics — whether SaaS subscription, per-trial fee, or services-led — cannot be confirmed. The aggregated dataset also contains extensive information about Fortrea (a separate, public, large-scale global CRO with 30+ years of history, a proprietary Fortrea Intelligent Technology™ platform, and operations spanning Biopharma/Biotech/MedTech). This Fortrea material appears as data contamination in the snapIoT file and is not used here to characterize snapIoT itself.

The company's competitive positioning is not well-evidenced. Nine years post-founding, snapIoT remains at 11-50 employees with no disclosed funding rounds, partnerships clearly attributable to the company, or named customers. This profile suggests an early-stage or self-funded operation whose commercialization scale is materially below the larger CROs (Fortrea) or venture-backed clinical trial SaaS platforms. Data gaps are significant: no revenue, no ARR, no product roadmap, no AI capabilities disclosure, and a single executive name (Isaac Eteminan) on record.

Short descriptiontext

snapIoT is a private, San Diego-based clinical trial platform founded in 2016 that designs tools to create, launch, and manage clinical trials. The company operates with 11-50 employees and is led by co-founder and CEO Isaac Eteminan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial management, eClinical platform, clinical research software, trial design software, clinical operations platform
Industry1 code
1Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryYes
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Management Software
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Fortrea Intelligent Technology™
Description

Technology platform enabling faster decision-making and exceptional customer experiences with solutions like FIT Lifecycle Solutions, FIT Foresight Solutions, and FIT Companion Solutions.

fortrea.com
Core offering1 text field

snapIoT is a clinical platform designed to create, launch, and manage clinical trials. The company provides a software platform for organizations conducting clinical research and drug development, supporting workflows associated with the design, initiation, and operational management of clinical studies.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1snapIoT Clinical Platform
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-04
Description

Strategic collaboration combining Fortrea's clinical development expertise with SCTbio's cGMP manufacturing capabilities for cell-based therapies and viral vectors. The partnership delivers integrated, end-to-end solutions for cell therapy innovators—streamlining timelines, reducing risks, and accelerating delivery of life-changing therapies worldwide.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medidata offers the Rave Clinical Cloud platform for EDC, CTMS, eCOA, and randomization in clinical trials, directly competing with snapIoT's clinical trial management and data capture focus.

TypeDirect peer
Description

Castor offers an EDC and eCRF platform for clinical trials, including decentralized trial capabilities, making it a direct competitor to snapIoT in clinical trial data capture and study management.

TypeDirect peer
Description

Anju Software provides clinical trial management and other life sciences software solutions, including its TrialMaster CTMS and EDC products, competing directly with snapIoT in clinical trial operations.

TypeDirect peer
Description

ArisGlobal provides LifeSphere Clinical Trial technology including CTMS, EDC, and eTMF solutions, directly competing with snapIoT's clinical trial platform focus across biopharma customers.

TypeDirect peer
Description

Bio-Optronics provides Clinical Conductor CTMS and other clinical trial management solutions, directly competing with snapIoT's clinical trial management focus for sponsors and sites.

TypeDirect peer
Description

Signant Health provides clinical trial technology solutions including eCOA, IRT, and patient engagement, making it a direct peer in clinical trial platform technology serving similar biopharma sponsors.

TypeDirect peer
Description

Veeva Systems provides Vault CTMS and other clinical trial management solutions to biopharma and CROs, making it a direct competitor to snapIoT's clinical trial platform across the same customer base.

TypeBroad incumbent
Description

Oracle's Clinical One platform provides unified clinical trial technology as part of its broader life sciences portfolio, competing broadly with snapIoT while offering substantially greater scale, integration, and installed customer base.

TypeDirect peer
Description

Clario provides clinical trial endpoint technology including eCOA, imaging, and respiratory solutions, competing with snapIoT in the clinical trial technology space serving biopharma and CRO customers.

TypeDirect peer
Description

Calyx provides EDC, IRT, and eCOA technology for clinical trials, directly competing with snapIoT in clinical trial data management and patient experience technology.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

snapIoT

Clinical Trial Management Softwaresnapiot.com

snapIoT is a private, San Diego-based clinical trial platform founded in 2016 that designs tools to create, launch, and manage clinical trials. The company operates with 11-50 employees and is led by co-founder and CEO Isaac Eteminan.

What snapIoT does

snapIoT is a privately held, San Diego-based clinical technology company founded in 2016. Per its own short description, snapIoT is "a clinical platform that designs to create, launch, and manage clinical trials." The company operates with 11-50 employees and is led by co-founder, CEO, and board member Isaac Eteminan. No additional product-level detail, technology stack, pricing model, or revenue mechanics are disclosed in the available data.

The business model is not explicitly stated beyond the platform's described function. By inference from the company description, snapIoT likely sells tooling or services to organizations conducting clinical trials (e.g., sponsors, CROs, sites), but the absence of pricing disclosures, named customers, and go-to-market detail means the revenue mechanics — whether SaaS subscription, per-trial fee, or services-led — cannot be confirmed. The aggregated dataset also contains extensive information about Fortrea (a separate, public, large-scale global CRO with 30+ years of history, a proprietary Fortrea Intelligent Technology™ platform, and operations spanning Biopharma/Biotech/MedTech). This Fortrea material appears as data contamination in the snapIoT file and is not used here to characterize snapIoT itself.

The company's competitive positioning is not well-evidenced. Nine years post-founding, snapIoT remains at 11-50 employees with no disclosed funding rounds, partnerships clearly attributable to the company, or named customers. This profile suggests an early-stage or self-funded operation whose commercialization scale is materially below the larger CROs (Fortrea) or venture-backed clinical trial SaaS platforms. Data gaps are significant: no revenue, no ARR, no product roadmap, no AI capabilities disclosure, and a single executive name (Isaac Eteminan) on record.

snapIoT firmographics

Firmographics
Name
snapIoT
Legal name
Fortrea Inc.
Website
https://snapiot.com
Company type
Public
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
snapIoT is a private, San Diego-based clinical trial platform founded in 2016 that designs tools to create, launch, and manage clinical trials. The company operates with 11-50 employees and is led by co-founder and CEO Isaac Eteminan.
Ownership category
akta.pro rank

snapIoT industry classification

Industry
Product category
Clinical Trial Management Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

  • Clinical trial management
  • EClinical platform
  • Clinical research software
  • Trial design software
  • Clinical operations platform

Where snapIoT is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

snapIoT business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels5 records

snapIoT product offering

Product offering

Core offering

snapIoT is a clinical platform designed to create, launch, and manage clinical trials. The company provides a software platform for organizations conducting clinical research and drug development, supporting workflows associated with the design, initiation, and operational management of clinical studies.

Differentiator

Problem solved

Functional benefit

Brands

  • Fortrea Intelligent Technology™: Technology platform enabling faster decision-making and exceptional customer experiences with solutions like FIT Lifecycle Solutions, FIT Foresight Solutions, and FIT Companion Solutions.

Products and services

  • snapIoT Clinical Platform

Companies that use snapIoT

Customer profile

Segments3 records

Ideal customer profiles1 record

snapIoT technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

snapIoT partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SCTbiocoreStrategic or Co-development Partner · 4 December 2025Strategic collaboration combining Fortrea's clinical development expertise with SCTbio's cGMP manufacturing capabilities for cell-based therapies and viral vectors. The partnership delivers integrated, end-to-end solutions for cell therapy innovators—streamlining timelines, reducing risks, and accelerating delivery of life-changing therapies worldwide.

Scale indicators1 record

Recent moves1 record

Expansion highlights2 records

snapIoT competitors and assessment

Company assessment

Direct peers

  • Medidata (Dassault Systèmes): Medidata offers the Rave Clinical Cloud platform for EDC, CTMS, eCOA, and randomization in clinical trials, directly competing with snapIoT's clinical trial management and data capture focus.
  • Castor: Castor offers an EDC and eCRF platform for clinical trials, including decentralized trial capabilities, making it a direct competitor to snapIoT in clinical trial data capture and study management.
  • Anju Software: Anju Software provides clinical trial management and other life sciences software solutions, including its TrialMaster CTMS and EDC products, competing directly with snapIoT in clinical trial operations.
  • ArisGlobal: ArisGlobal provides LifeSphere Clinical Trial technology including CTMS, EDC, and eTMF solutions, directly competing with snapIoT's clinical trial platform focus across biopharma customers.
  • Bio-Optronics: Bio-Optronics provides Clinical Conductor CTMS and other clinical trial management solutions, directly competing with snapIoT's clinical trial management focus for sponsors and sites.
  • Signant Health: Signant Health provides clinical trial technology solutions including eCOA, IRT, and patient engagement, making it a direct peer in clinical trial platform technology serving similar biopharma sponsors.
  • Veeva Systems: Veeva Systems provides Vault CTMS and other clinical trial management solutions to biopharma and CROs, making it a direct competitor to snapIoT's clinical trial platform across the same customer base.
  • Clario: Clario provides clinical trial endpoint technology including eCOA, imaging, and respiratory solutions, competing with snapIoT in the clinical trial technology space serving biopharma and CRO customers.
  • Calyx: Calyx provides EDC, IRT, and eCOA technology for clinical trials, directly competing with snapIoT in clinical trial data management and patient experience technology.

Broad incumbents

  • Oracle Health Sciences (Clinical One): Oracle's Clinical One platform provides unified clinical trial technology as part of its broader life sciences portfolio, competing broadly with snapIoT while offering substantially greater scale, integration, and installed customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

snapIoT social profiles

Digital presence

snapIoT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

snapIoT leadership team

Management profile

Number of profiles

Profiles1 record

snapIoT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

snapIoT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about snapIoT

What does snapIoT do?

snapIoT is a clinical platform designed to create, launch, and manage clinical trials. The company provides a software platform for organizations conducting clinical research and drug development, supporting workflows associated with the design, initiation, and operational management of clinical studies.

Is snapIoT a public or private company?

snapIoT is a public company. It is classified as founder individual operated bootstrapped and is currently operating.

When was snapIoT founded?

snapIoT was founded in 2016. It employs 11 to 50 people.

Where is snapIoT based?

snapIoT is headquartered in San Diego, United States, in the North America region.

Who are snapIoT's main competitors?

Direct peers on record are Medidata (Dassault Systèmes), Castor, Anju Software, ArisGlobal, Bio-Optronics, Signant Health, Veeva Systems, Clario and Calyx. Oracle Health Sciences (Clinical One) is listed as a broad incumbent.

Does snapIoT have an API?

No public API is recorded for snapIoT.

What industry is snapIoT in?

snapIoT's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales